NPP Seminar: Professor Zoltan Nusser, HUN-REN Institute of Experimental Medicine, Budapest, Hungary
Title: Differential synaptic vesicle priming underlies heterogeneity in presynaptic release probability
Abstract: It has been known for decades that chemical synapses of the CNS show tremendous functional, and structural diversity. Understanding the molecular mechanisms underlying functional synaptic diversity is a major challenge and has been the focus of our research in the past decades. One of the most intriguing examples of synaptic diversity is the so-called postsynaptic target cell type-dependent variations in the presynaptic glutamate release in cortical/hippocampal circuits.
The probability of glutamate release from hippocampal pyramidal cell (PC) axons that innervate oriens-lacunosum-moleculare (O-LM) interneurons is 10-fold lower than that innervating fast-spiking interneurons (FSINs). Pharmacological experiments demonstrated that the major difference between these two hippocampal synapses is their differential sensitivity to PDBU, indicating differential priming states of the SV. A sequential two-step priming model of synaptic transmission predicted a 6.5-fold smaller fraction of properly primed SVs at PC – O-LM synapses compared to those at PC – FSIN synapses, whereas the fusion probability of properly primed SVs is only 40% lower at PC – O-LM synapses. Using transgenic mice in which a single amino acid of Munc13-1 is mutated (H567K) we provide unequivocal evidence that the postsynaptic target cell type-dependent variability in presynaptic glutamate release in hippocampal network is the consequence of variability in SV priming, rather than differences in fusion of SVs.It has been known for decades that chemical synapses of the CNS show tremendous functional, and structural diversity. Understanding the molecular mechanisms underlying functional synaptic diversity is a major challenge and has been the focus of our research in the past decades.
One of the most intriguing examples of synaptic diversity is the so-called postsynaptic target cell type-dependent variations in the presynaptic glutamate release in cortical/hippocampal circuits. The probability of glutamate release from hippocampal pyramidal cell (PC) axons that innervate oriens-lacunosum-moleculare (O-LM) interneurons is 10-fold lower than that innervating fast-spiking interneurons (FSINs). Pharmacological experiments demonstrated that the major difference between these two hippocampal synapses is their differential sensitivity to PDBU, indicating differential priming states of the SV. A sequential two-step priming model of synaptic transmission predicted a 6.5-fold smaller fraction of properly primed SVs at PC – O-LM synapses compared to those at PC – FSIN synapses, whereas the fusion probability of properly primed SVs is only 40% lower at PC – O-LM synapses. Using transgenic mice in which a single amino acid of Munc13-1 is mutated (H567K) we provide unequivocal evidence that the postsynaptic target cell type-dependent variability in presynaptic glutamate release in hippocampal network is the consequence of variability in SV priming, rather than differences in fusion of SVs.
Academic Host: Angus Silver, NPP
Deputy director of the Institute of Experimental Medicine, Budapest, Hungary.
HUN-REN Institute of Experimental Medicine, Budapest, Hungary
Zoltan Nusser graduated from the University of Oxford in 1995. Then, he studied cellular neurophysiology as a postdoctoral scientist in the laboratory of Stuart Cull-Candy at UCL, and in the laboratory of Istvan Mody at UCLA. In 2000, he established his research group in the Institute of Experimental Medicine, Budapest. His research interest focuses on understanding synaptic communication between nerve cells.
He has received a Postdoctoral Fellowship from the Boehringer Ingelheim Fonds (2000-2006), an International Research Scholarship from the Howard Hughes Medical Institute (2000-2005), and an International Senior Research Fellowship from the Wellcome Trust (2003-2006). He was also the recipient of a European Young Investigator Award (2006-2011) and two European Research Council Advanced Grants (2012-2017, 2018-2023). He was awarded the Ignaz L. Lieben Award of the Austrian Academy of Sciences in 2004, the FENS Boehringer Prize in 2006 and the Debiopharm Life Sciences Award in 2007. In 2007 he was elected as a fellow of the Hungarian Academy of Sciences and in 2011 Member of the Academia Europaea. He is currently the deputy director of the Institute of Experimental Medicine, Budapest, Hungary.
Further information
Ticketing
Open
Cost
Free
Open to
All
Availability
Yes